Clinical Trials in Oncology - 29-30 November and 1 December 2010 – Munich, Germany
Tuesday 30 November 2010 and Wednesday 1 November 2010 , Munich, Germany
Through case study driven presentations from leading pharmaceutical and biotech companies, panel discussions, and a series of interactive roundtable discussions, this event will provide strategic, scientific, and operational solutions to face the current and upcoming challenges in the field. •Take away applicable, implementable strategies relevant to your ongoing and future trials and development plans from successful case studies •Exploit new opportunities in targeted therapies whilst mitigating risks •Learn directly from the leaders and implementers of cutting edge biomarker and adaptive projects •Explore what works and what doesn’t in oncology drug development in Europe and further afield, through the lessons learned by operational experts, project leaders, and regulatory authorities in clinical trials in oncology Learn how to: •Expedite and strengthen Phases I-III through innovative and effective proven methods of improving suitability of trial setup •Optimise candidate and investigator engagement and patient recruitment through use of innovative and effective marketing of your trial within varying European guidelines •Exploit opportunities, possibilities and rewards of biomarker-led drug development through establishing how to tackle the hurdles and minimise procedural obstacles in adaptive trials and personalised medicine •Achieve optimal trial development through full understanding of regulation, exploitation of regulatory advisory services and tips on time-effective application and submission •Select the most suitable primary endpoint to ensure positive implications for cost control, funding, licensing and reimbursement
